Back
Regeneron Pharmaceuticals Stock Price Chart
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Sell
42
REGN
Regeneron Pharmaceuticals
Last Price:
828.36
Seasonality Move:
11.8%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing slight buying pressure.
Regeneron Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 841.56 | Sell |
| 20-day SMA: | 918.41 | Sell |
| 50-day SMA: | 1025.36 | Sell |
| 200-day SMA: | 1010.07 | Sell |
| 8-day EMA: | 847.36 | Sell |
| 20-day EMA: | 904.35 | Sell |
| 50-day EMA: | 984.39 | Sell |
| 200-day EMA: | 994.73 | Sell |
Regeneron Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -59.11 | Sell |
| Relative Strength Index (14 RSI): | 18.63 | Sell |
| Chaikin Money Flow: | 231296 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (862.91 - 1008.59) | Sell |
| Bollinger Bands (100): | (967.48 - 1155.78) | Sell |
Regeneron Pharmaceuticals Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Regeneron Pharmaceuticals Stock
Is Regeneron Pharmaceuticals Stock a Buy?
- Regeneron Pharmaceuticals share price is 828.42 while REGN 8-day simple moving average is 841.56, which is a Sell signal.
- The stock price of REGN is 828.42 while Regeneron Pharmaceuticals 20-day SMA is 918.41, which makes it a Sell.
- Regeneron Pharmaceuticals 50-day simple moving average is 1,025.36 while REGN share price is 828.42, making it a Sell technically.
- REGN stock price is 828.42 and Regeneron Pharmaceuticals 200-day simple moving average is 1,010.07, creating a Sell signal.
REGN Technical Analysis vs Fundamental Analysis
Sell
42
Regeneron Pharmaceuticals (REGN)
is a Sell
Is Regeneron Pharmaceuticals a Buy or a Sell?
-
Regeneron Pharmaceuticals stock is rated a Sell
The current Regeneron Pharmaceuticals [REGN] share price is $828.42. The Score for REGN is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
Regeneron Pharmaceuticals Stock Info
Market Cap:
91.03B
Price in USD:
828.42
Share Volume:
554.13K
Regeneron Pharmaceuticals 52-Week Range
52-Week High:
1,211.20
52-Week Low:
783.57
Sell
42
Regeneron Pharmaceuticals (REGN)
is a Sell
Regeneron Pharmaceuticals Share Price Forecast
-
What is the Regeneron Pharmaceuticals stock price today?
The Regeneron Pharmaceuticals stock price is 828.42 USD today. -
Will REGN stock go up or go down?
Regeneron Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Regeneron Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Regeneron Pharmaceuticals is overvalued.
Is Regeneron Pharmaceuticals Stock a Buy?
- Regeneron Pharmaceuticals share price is 828.42 while REGN 8-day exponential moving average is 847.36, which is a Sell signal.
- The stock price of REGN is 828.42 while Regeneron Pharmaceuticals 20-day EMA is 904.35, which makes it a Sell.
- Regeneron Pharmaceuticals 50-day exponential moving average is 984.39 while REGN share price is 828.42, making it a Sell technically.
- REGN stock price is 828.42 and Regeneron Pharmaceuticals 200-day simple moving average is 994.73, creating a Sell signal.
Fundamental Analysis of Regeneron Pharmaceuticals
Is Regeneron Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $2.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.45 per share, and an increase next year of $0.57 per share.
Technical Analysis of Regeneron Pharmaceuticals
Should I short Regeneron Pharmaceuticals stock?
- REGN Moving Average Covergence Divergence (MACD) indicator is -59.11, suggesting Regeneron Pharmaceuticals is a Sell
- Regeneron Pharmaceuticals Relative Strength Index (RSI) is 18.63, which suggest Regeneron Pharmaceuticals is oversold
- The Bollinger Bands (25) for Regeneron Pharmaceuticals is (862.91 - 1008.59), which suggest Regeneron Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Regeneron Pharmaceuticals is (967.48 - 1155.78), which suggest Regeneron Pharmaceuticals is a Sell
* Regeneron Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.